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Purpose: Ventilator-associated pneumonia (VAP) is a nosocomial infection resulting in 
significant morbidity and mortality. Pseudomonas aeruginosa (P. aeruginosa) and Staphylococcus 
aureus (S. aureus) are pathogens associated with VAP. Silver (Ag) coating of endotracheal 
tubes (ETTs) reduces bacterial colonization, however titanium dioxide (TiO2) coating has not 
been studied.
Methods: Five types of ETT coatings were applied over silica layer: Ag, solgel TiO2, solgel 
TiO2 with Ag, Degussa P25 TiO2 (Degussa TiO2), and Degussa TiO2 with Ag. After ETTs were 
incubated with P. aeruginosa or S. aureus; colonization was determined quantitatively.
Results: Pseudomonas aeruginosa and S. aureus grew for 5 days on standard ETTs. Compared 
to standard ETTs, P. aeruginosa growth was significantly inhibited by solgel TiO2 with Ag at 
24 hours, and by Degussa TiO2 with Ag at 24 and 48 hours after inoculation. No significant 
difference in S. aureus growth was observed between the control and any of the five coatings 
for 5 days.
Conclusion: In vitro, solgel TiO2 with Ag and Degussa TiO2 with Ag both attenuated 
P. aeruginosa growth, but demonstrated no effect on S. aureus colonization. Further studies 
using alternative coating and incorporating UV light exposure are needed to identify their 
potential utility in reducing VAP.
Keywords: ventilator-associated pneumonia, Degussa titanium dioxide, solgel titanium dioxide, 
quantitative culture
Introduction
Ventilator-associated pneumonia (VAP) is one of the most common nosocomial infec-
tions among intensive care unit patients, which prolongs ventilation and hospitalization, 
resulting in significant morbidity, mortality and medical costs.1–3 Researchers have 
developed strategies to prevent VAP, including controlling gastric pH, intratracheal 
intubation with a high-pressure endotracheal tube (ETT) cuff, continuous subglottic 
suction to prevent microaspiration, promoting oral hygiene with chlorhexidine, and 
semi-recumbent positioning.4–9
One strategy to reduce VAP is to treat the ETT with an antiseptic agent to control 
ETT biofilm formation.10,11 A biofilm is an aggregate of a bacterial community attached 
to a solid surface and encased in an exopolysaccharide matrix, making it resistant to 
antibiotic penetration.12 Biofilm formation is most prominent in the distal third of the 
ETT and can occur as early as sixty hours following endotracheal intubation.13Dovepress
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Due to silver’s antimicrobial properties, Pacheco-Fowler 
and colleagues studied chlorhexidine and Ag carbonate 
impregnated ETTs in an in vitro model and observed that 
bacterial growth of S. aureus, P. aeruginosa, and other 
organisms was attenuated.14 Similarly, Rello et al found that 
bacterial colonization was delayed for seven days in adults 
intubated with Ag-coated ETTs compared with standard 
ETTs,15 and Kollef and colleagues concluded a statistically 
significant reduction in the VAP incidence in a randomized 
multicenter trial.16
Titanium dioxide is widely used as an antimicrobial 
agent, but it is not commonly employed in the medical set-
ting. In a process known as photocatalysis, TiO2 is activated 
into potent oxidative species when exposed to UV light, 
with antiviral, antibacterial as well as fungicidal actions.17 
Recent, investigations have suggested that the photocatalytic 
  activity is important in destroying a range of bacteria 
  including S. aureus and P. aeruginosa in aqueous solutions.18 
  Photocatalytic activity also is implicated in the inhibition 
of biofilm formation on TiO2 based dental implants.19,20 In 
view of these antimicrobial actions it is plausible that TiO2-
  coating of ETTs, potentially in combination with UV light, 
may sterilize ETTs in patients’ airways, thereby reducing 
the risk of VAP.
We conducted a pilot study of bacterial growth 
behavior on TiO2-coated ETTs without UV exposure to 
evaluate the antimicrobial effect of TiO2 on polyvinyl 
chloride (PVC) which is used to manufacture ETTs. Initial 
experiments examined TiO2 without UV light exposure 
for two reasons. First, the Ag and TiO2 combination has 
not been studied on PVC material. Second, if the Ag and 
TiO2 coating has antimicrobial activity without photo-
catalysis, this would reduce potential toxicity from UV 
exposure. The objective of this study was to determine 
if TiO2-coated ETTs with or without Ag would reduce 
bacterial colonization by two common VAP pathogens (ie, 
P. aeruginosa or S. aureus) in an in vitro model compared 
with standard ETTs.
Material and methods
Solgel TiO2 synthesis
Sols of TiO2 were made using a method adapted from Mills 
and colleagues.21 A solution of 10 mL titanium isopropoxide 
(AC19470 98+%; Acros Organics, Geel, Belgium) in 2.32 g 
glacial acetic acid (A465-250; Fisher Chemical, Pittsburgh, 
PA), was stirred into 60 mL deionized water acidified with 
0.59 g concentrated nitric acid (S719721; Fisher Chemical). 
The reaction solution was then heated rapidly and held at 
80°C for 8 hours. The solution was concentrated by heating 
at 150°C to 11 wt% TiO2 followed by dilution with ethanol 
(AC61510; Acros Organics) to obtain a translucent white sol 
containing 6 wt% TiO2 sol.
Endotracheal tubes
The inner lumens of the ETTs were first coated with silica 
(SiO2) which served as a passivating layer to prevent the 
TiO2 from degrading the polyvinyl chloride (PVC) and to 
improve surface wettability by the subsequently applied 
TiO2 coatings. The SiO2 layer was applied using a nebulizer 
spray of 15 wt% colloidal SiO2 in deionized water through 
the ETT, through a custom-designed nozzle, for 1 minute 
with an air flow rate of 10 liters per minute. The ETT was 
then dried with 85°C air for 1 minute.
The respective TiO2 and Ag treatments are summarized 
in Table 1. Five types of coatings were applied over the SiO2 
layer (Figure 1): 1) solgel TiO2, 2) solgel TiO2 with Ag, 
3) Degussa TiO2 (Evonik Degussa, Parsippany, NJ, USA), 4) 
Degussa TiO2 with Ag, and 5) Ag (not shown in Figure 1). 
Each of the coating solutions A–D had 0.19 wt% TiO2 on a 
dry weight basis. Water and ethanol were used as solvents 
in variable ratios for each solution. Solgel TiO2 was used 
for solutions A and B, while C and D solutions consisted 
of solgel and Degussa TiO2 in the ratio 20:80 wt/wt. Silver 
nitrate (AgNO3) was added to solutions B and D. For solution 
E, AgNO3 0.1 wt% was mixed in ethanol-water (50:50 
wt/wt). Two types of TiO2 coatings were applied; solgel 
Table 1 Coating solutions with their respective titanium dioxide and silver treatments
Tube Solution TiO2 source Solvent AgNO3: TiO2 (mol%)
1 A Solgel Water: Ethanol (60:40) 0
2 B Solgel Water: Ethanol (60:40) 5.6
3 C Solgel: Degussa (20:80) Water: Ethanol (3:97) 0
4 D Solgel: Degussa (20:80) Water: Ethanol (5:95) 5.6
5 E No TiO2 Water: Ethanol (50:50) 0.1wt% AgNO3
Abbreviations: Ag, silver; AgNO3, silver nitrate; Degussa TiO2, Degussa P25 titanium dioxide; TiO2, titanium dioxide.Dovepress
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Figure 1 Standard endotracheal tubes were coated with a passivating layer of colloidal 
silica and served as controls. Five types of coatings were applied over a silica layer; 1. 
solgel titanium dioxide without silver, 2. solgel titanium dioxide with silver, 3. Degussa 
titanium dioxide without silver, 4. Degussa titanium dioxide with silver and 5. silver only 
(not shown).
to increase adherence to PVC for substrate depositition 
and Degussa TiO2 for potentially high photocatalytic 
  performance. Since Degussa TiO2 suspensions had very 
poor adhesion to the ETTs, they were mixed with a small 
amount of sols of solgel TiO2. After TiO2 coating, the ETTs 
were dried with 85°C air for 1 minute, followed by further 
drying in an air-circulating oven at 100°C for 15 minutes, 
then packed while warm.
Preparation of P. aeruginosa
Freeze-dried P. aeruginosa (ATCC #25668; American Type 
Culture Collection, Manassas, VA, USA) was rehydrated 
with nutrient broth in aliquots to be stored at -80°C. After a 
loopful of frozen bacteria was plated and incubated, a single 
colony was inoculated into 4 mL tryptic soy broth (TSB) and 
incubated overnight at 37°C. The following day, the turbid 
bacterial broth was vortexed and inoculated. To determine the 
exact inoculums, 100µL of bacterial broth was serially diluted 
with phosphate-buffered saline (PBS), then optical density 
was measured to obtain 108 colony forming units/milliliter 
(CFU/mL).
Preparation of S. aureus
Frozen S. aureus (ATCC #25923) was rehydrated with TSB 
in the same fashion as P. aeruginosa, and stored at -80°C. 
Frozen S. aureus was inoculated into 50 mL TSB in a 
flask, and incubated overnight at 37°C. Turbid S. aureus 
  bacterial broth was transferred to a 50 mL sterile culture 
tube, centrifuged for 15 minutes, and the supernatant was 
discarded. A concentrated broth was made by the addition of 
1 mL of TSB to the pellet of S. aureus. Optical density was 
measured to obtain 109 CFU/mL for ETT inoculation.
Bacterial inoculation of ETTs
Each ETT was marked at 4 cm intervals for later division 
into six equal pieces, then immersed in 75% alcohol for 
15 minutes to sterilize, rinsed with 20 mL 0.9% sterile saline, 
and air dried. After sterilization, each ETT was cut into six 
pieces, sealed on one end with Tegaderm® (3M, St. Paul, 
MN), filled with either 8 µl of P. aeruginosa broth plus 
800 µl TSB or 100 µl S. aureus broth plus 700 µl TSB, 
then sealed with Tegaderm. All ETT pieces were placed in 
a 2 liter dry flask and agitated at 37°C overnight. On the 
following day, the bacterial fluid was drained from each 
ETT piece.
Peroxidase assay after coating ETTs
Colorimetric measurement was used to detect whether TiO2 
on ETTs generated peroxidase as part its antimicrobial 
  property. EM Quant Peroxide Test Strips (EMD Chemicals 
Inc. Gibbstown, NJ, USA) which measure peroxidase 
between 1–100 parts-per million were used. Trypic soy broth 
800 µL was placed on the TiO2-coated ETT for 24 hours at 
37°C in the dark. Following incubation, the colorimetric 
strip was dipped into the TSB and the value of peroxidase 
production was determined.
Observation of bacterial growth
Bacterial inoculated ETT pieces were placed in an incubator 
to simulate the in vitro human trachea with no ambient 
light, a relative humidity of 90%, temperature of 37°C 
and at standard atmospheric pressure. Bacterial growth 
was observed for 24, 48, 72, 96, 120, and 144 hours after 
  inoculation on the standard and five test ETTs. The inner 
surface of bacteria was collected by washing with 0.5 mL of 
sterile PBS and swabbing every 24 hours after inoculation. 
The collected fluid was serially diluted and plated on tryptic 
soy agar for incubation overnight at 37°C. Colony counts 
were expressed as CFU/mL, and each experiment was 
repeated four times.Dovepress
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Statistical analysis
Data were reported as mean ± standard error of mean (SEM). 
Bacterial colony counts were analyzed using Mann–Whitney 
U test comparing coated ETTs with standard ETTs. A P-value 
of  0.05 was considered statistically significant.
Results
The coating was slightly opaque using solgel TiO2 compared 
with Degussa TiO2. Samples with Ag-containing coatings 
appeared dark due to the reduction of AgNO3 to Ag. The coating 
was particulate in appearance to the naked eye and peeled off 
while collecting the bacteria by mechanical force. Peroxidase 
production was not detected on TiO2-coated ETTs.
Pseudomonas aeruginosa
Growth peaked at 72 hours and continued for 144 hours on 
standard ETTs. Pseudomonas aeruginosa growth was more 
robust on Ag-coated ETTs compared to standard ETTs at 
120 hours (P = 0.04) and 144 hours (P = 0.06) despite initial 
slow growth in the first 24 hours (Figure 2). There was no differ-
ence in P. aeruginosa growth over 144 hours among standard, 
solgel TiO2 and Degussa TiO2-coated ETTs (Figure 3). 
Compared to standard ETTs, solgel TiO2 with Ag inhibited 
P. aeruginosa growth at 24 hours (P = 0.02), and Degussa TiO2 
with Ag inhibited P. aeruginosa growth at 24 and 48 hours after 
inoculation (P = 0.02 and P = 0.02, respectively) (Figure 4).
Staphylococcus aureus
Growth was observed up to 144 hours. Staphylococcus aureus 
growth peaked at 48 hours after inoculation on both standard 
and Ag-coated ETTs without a difference over 144 hours 
(Figure 5). Furthermore, there was also no difference in 
S. aureus growth over 144 hours between standard, solgel 
TiO2 and Degussa TiO2-coated ETTs (Figure 6). Compared to 
standard ETTs, neither solgel TiO2 with Ag nor Degussa TiO2 
with Ag showed a difference in S. aureus growth over a 144 
hour period except solgel TiO2 with Ag at the 144 hour point 
after inoculation in which there was a significant attenuation of 
S. aureus growth compared to the standard ETT (Figure 7).
Discussion
Clinically, VAP is diagnosed after patients have been 
mechanically ventilated for more than 48 hours similar to 
the duration of bacterial growth in our simulated model. 
The growth of P. aeruginosa was consistent with the find-
ings of other investigators under comparable conditions 
when monitoring growth in the first 24 hours.22,23 An initial 
suppression of P. aeruginosa in Ag-coated ETT was also 
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Figure 2 Characterization of P. aeruginosa growth on polyvinyl chloride endotracheal 
tubes over a 144-hour period. Comparison of standard and silver only coated en-
dotracheal tubes. There was less P. aeruginosa growth on silver-coated endotracheal 
tubes at 24 hours (P  0.01), but more growth at 120 hours (P = 0.04) and 144 hours 
(P = 0.06) compared to standard endotracheal tubes.
Notes: Mean ± standard error of mean, *P  0.05 compared to standard endotra-
cheal tube. N = 4.
Abbreviation: CFU, colony-forming units.
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Figure 3 Characterization of P. aeruginosa growth on polyvinyl chloride endotracheal 
tubes coated with titanium dioxide over 144 hour period. Comparison of standard, 
solgel titanium dioxide and Degussa titanium dioxide endotracheal tubes. 
P. aeruginosa growth was not statistically significant at all time points.
Notes: Mean ± standard error of mean, N = 4.
Abbreviation: CFU, colony-forming units.Dovepress
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observed in sections of intraventricular tubing impregnated 
with Ag.23 Moreover, our experience was similar to results of 
others who observed an undulating pattern of bacterial growth 
over a 50 hour period in Ag-coated ETTs.24 The second   
P. aeruginosa growth peak observed in Figure 2 was thought 
to be an experimental variation due to the small sample size.
A similar growth pattern on Ag-coated ETT was also 
observed in a study evaluating the growth of P. aeruginosa and 
S. aureus on PVC even in the presence of antimicrobials. Both 
P. aeruginosa and S. aureus produce a biofilm; its robustness 
is strain dependent.25–27 Biofilm generating species of S. aureus 
exhibit accelerating growth kinetics in the first 6 days in animal 
models. Furthermore, these strains form microcolonies on cath-
eter substrates that serve as sites of biofilm formation.28 Thus, 
it is likely that S. aureus growth was probably blunted in our 
model until a glycocalyx developed, then growth proceeded 
in the presence of nutrients and favorable conditions.
The antimicrobial properties of Ag result from Ag ions 
binding to bacterial sulphydryl- or histidyl-containing 
  proteins, which disrupt transmembranous energy metabolism 
and electrolyte transport systems.29 Because the cell wall 
composition and thickness vary between gram positive and 
gram negative bacteria, silver’s antimicrobial effect may be 
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Figure 4 Characterization of P. aeruginosa growth on polyvinyl chloride endotracheal 
tubes coated with titanium dioxide with silver over a 144-hour period. Comparison 
of standard, solgel titanium dioxide with silver, and Degussa titanium dioxide with 
silver endotracheal tubes. P. aeruginosa growth was inhibited significantly by solgel 
titanium dioxide with silver at 24 hours and by Degussa titanium dioxide with silver 
at 24 and 48 hours, respectively.
Notes: Mean ± standard error of mean; *P  0.05 compared to standard endotra-
cheal tube, # P  0.05 compared to standard endotracheal tube. N = 4.
Abbreviation: CFU, colony-forming units.
greater in P. aerugionsa than in S. aureus during the initial 
phase of bacterial multiplication.
The characteristics of discolored Ag-coated particles 
were not analyzed in this experiment. However, AgNO3 is 
known to undergo photochemical reduction to metallic Ag 
upon exposure to light as described by the reaction:
2AgNO3 → 2Ag + 2NO2 + O2
This leads to the tiny particles precipitation of Ag that 
appears black or brown. Future studies are needed to define 
the specific mechanism involved in the antimicrobial proper-
ties of Ag as well as the physiological impact of discolored 
Ag. Silver nitrate was not expected to react with SiO2 under 
ambient conditions, since SiO2 is quite nonreactive.
Application and treatment of ETTs with these chemicals 
may also change the surface charge and hydrophobicity, as 
in this study, thus changing the PVC characteristics from 
hydrophobic to hydrophilic.
This study demonstrated that the addition of TiO2 
  significantly augmented the antibacterial effects of Ag on 
P. aeruginosa during the first 72 hours, but had no effect on 
S. aureus. In our limited study, TiO2 photocatalysis was not 
observed as determined by the release of hydrogen peroxide 
24 48 72 96 120 144
Time (h)
2.0
1.6
1.2
0.8
0.4
0.0
M
e
a
n
 
C
F
U
/
m
l
 
(
b
i
l
l
i
o
n
s
)
Ag
Standard
Figure 5 Characterization of S. aureus growth on polyvinyl chloride endotracheal 
tubes coated with silver only over a 144-hour period. Comparison of standard and 
  silver only coated endotracheal tubes. There was no difference in S. aureus growth 
between standard and silver coated endotracheal tubes at any time point over 144 
hours compared with standard endotracheal tubes.
Note: N = 4.
Abbreviation: CFU, colony-forming units.Dovepress
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Figure 6 Characterization of S. aureus growth on polyvinyl chloride endotracheal 
tubes coated with titanium dioxide only over a 144-hour period. Comparison of 
standard, solgel titanium dioxide and Degussa titanium dioxide endotracheal tubes. 
There was no difference in S. aureus growth in the titanium dioxide-coated groups 
compared to standard endotracheal tubes at any time point. 
Note: N = 4.
Abbreviation: CFU, colony-forming units.
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Figure 7 Characterization of S. aureus growth on polyvinyl chloride endotracheal 
tubes coated with titanium dioxide with silver over a 144-hour period. Comparison 
of standard, solgel titanium dioxide with silver and Degussa titanium dioxide with 
silver endotracheal tubes. There was no difference in S. aureus growth in the titanium 
dioxide with silver-coated groups compared to standard endotracheal tubes except 
at 144 hours with solgel titanium dioxide with silver endotracheal tubes.
Note: N = 4.
Abbreviation: CFU, colony-forming units.
as a part of reactive oxygen species. Silver and TiO2 might 
have reacted with each other releasing Ag ion, and this 
  reactant might have a synergistic antimicrobial effect even 
in a dark environment without photocatalysis.
In contrast, Yao showed that application of thin films 
of Ag and TiO2 for sterilization purposes on silicone cath-
eters promptly eliminates S. aureus within 90 minutes 
without TiO2-photocatalysis. They also showed inhibition 
of growth of Escherichia coli (E. coli) and P. aeruginosa, 
although they only observed growth for 24 hours.30 Li and 
colleagues demonstrated that AgNO3 and TiO2 pulverized 
to surgical masks reduced E. coli and S. aureus by 100%. 
In Li’s study, Ag plus TiO2 pulverized masks were 
exposed to UV-C irradiation prior to bacterial inoculation.31 
  Pseudomonas aeruginosa behaves very differently in the ini-
tial phase of bacterial attachment to the surface compared to   
S. aureus. Rogers and colleagues demonstrated that S. aureus 
  multiplies and produces a biofilm on the surface that thickens 
  monotonically, becoming hard during growth and softening 
during starvation. In comparison, P. aeruginosa showed 
much less reproducible behavior; the organism was loosely 
adhered and detached from the surface after several hours 
in vitro.32 Until P. aerugionosa attachment is established, 
this initial motile motion phase may be inhibited or delayed 
by synergistic bactericidal activity of Ag and either form of 
TiO2 as we demonstrated.
Our study has several limitations. First, it was conducted 
in an in vitro model that was designed to replicate the 
human tracheal environment. However, the results may not 
be applicable to the in vivo setting where other factors may 
impact the ETT surface such as frequent suctioning, nebulizer 
therapy or host factors. Second, the concomitant use of Ag 
and TiO2 would seem to be marginally effective against VAP 
if it does not inhibit a common cause of VAP (ie, S. aureus). 
Third, minimizing the particulate surface that facilitates 
bacterial binding could be effective by reducing the surface 
area for bacterial adherence and growth. Fourth, the coating, 
peeled off under mechanical stress, could be dislodged by a 
suction catheter and produce potentially harmful Ag particles 
in the human airway and lung parenchyma. Nevertheless, 
titanium dioxide is known to be safe in humans and is used 
in such products as cosmetics, toothpaste, and sun screen. 
Hence, the combination of Ag and TiO2 needs to be evaluated 
in a clinical setting. Lastly, this study did not directly evaluate 
the attractive feature of TiO2 photocatalysis. The potency of 
TiO2 either individually or in combination with Ag needs to International Journal of Nanomedicine
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be examined in conjunction with photocatalysis. However, 
exposing tracheal mucosa to UV light involves potential 
toxicity. This potential risk and, more importantly, its clinical 
feasibility, need to be ascertained in future studies.
Conclusion
One strategy to reduce the incidence of VAP is to pretreat ETT 
with an antiseptic agent to reduce or delay bacterial biofilm 
formation. The use of TiO2 with Ag-coated ETTs effectively 
inhibited P. aeruginosa growth, but not S. aureus growth, in 
an in vitro model of a human trachea environment.
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